# U.S. Pharmaceutical Industry

Type: Company

Source: Supply Chain Intelligence Brief — https://getsupplybrief.com/entity/us-pharmaceutical-industry
Canonical HTML page: https://getsupplybrief.com/entity/us-pharmaceutical-industry

## Timeline

- **2026-07-25T00:01:00-05:00**: New Tariffs Take Effect — The global 10% tariff expires and is replaced by 10% and 12.5% rates on imports from 60 trading partners; Canadian import fees also begin.
- **2026-07-24**: New Tariff Package Announced — The White House unveils a new tariff structure to take effect at midnight, with two tiers targeting 60 countries, alongside fees on Canadian goods and a threat of pharmaceutical levies.
- **2026-03-01**: Temporary 10% Global Tariff Imposed — Administration enacts a 10% across-the-board tariff under a different statutory authority, designed as a bridge while crafting a permanent replacement.
- **2026-02-20**: Supreme Court Strikes Down IEEPA Tariffs — The Supreme Court rules that President Trump's use of the International Emergency Economic Powers Act to impose broad tariffs is unlawful, dealing a major legal blow to his trade policy.
- **2026-02-20**: Trump Vows to Use Alternatives — Hours after the ruling, Trump holds a press briefing declaring he will use 'great alternatives' to replace the rejected tariffs, signaling no retreat.

## Recent coverage (1 stories)

### New 12.5% Tariffs Hit 60 Nations, Forcing Immediate Supply Chain Realignment
2026-07-24 16:55:42 · Sentiment: Bearish · Impact: 6/10 · Sources: 6

The overnight replacement of a uniform 10% tariff with a tiered system of 10% and 12.5% on 60 trading partners, plus new Canadian fees, compels supply chain managers to rapidly recalculate landed costs and evaluate supplier diversification. The threat of pharmaceutical tariffs adds another layer of risk for logistics and procurement teams.
Full story: https://getsupplybrief.com/story/supply-chain-tariffs-60-nations-12-percent

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getsupplybrief.com/guides/methodology for the full editorial methodology.